Table 2.
Clinical and demographic correlates of longitudinal anti-spike IgG antibody response following complete initial mRNA vaccination
| Beta* | SE | P value | Partial R2 | |
| Prior SARS-CoV-2 infection | 1.74 | 0.11 | <0.001 | 0.134 |
| Age (year) | −0.01 | 0.00 | <0.001 | 0.016 |
| Male sex | −0.27 | 0.06 | <0.001 | 0.013 |
| Non-white race | −0.00 | 0.06 | 0.99 | 0.000 |
| Hispanic ethnicity | 0.02 | 0.10 | 0.80 | 0.000 |
| Obesity | 0.03 | 0.09 | 0.77 | 0.000 |
| Hypertension | −0.17 | 0.08 | 0.041 | 0.003 |
| Charlson Comorbidity Index | −0.02 | 0.03 | 0.56 | 0.000 |
*Beta values represent increase in 1 SD of log(10)IgG-S level per presence (vs absence) of a categorical variable or per unit increment of continuous variable.